
Glimrox MP 1mg/500mg/15mg Tablet SR
Marketer
Deltis Pharma Private Limited
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimrox MP 1mg/500mg/15mg Tablet SR
Metformin/Pioglitazone/Glyburide extended-release tablets (1mg/500mg/15mg) manage blood glucose in adults with type 2 diabetes. This triple-combination therapy complements diet and exercise to improve glycemic control. It enhances insulin effectiveness, reducing blood sugar. Always adhere to your physician's prescribed dosage and regimen. Take with food to prevent digestive discomfort. Missed doses should be taken promptly unless the next dose is imminent; never double a dose. Overdosage can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to use, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation. Kidney function will be assessed before treatment commences. Limit alcohol consumption to minimize potential adverse reactions.
Uses of Glimrox MP 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimrox MP 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimrox MP 1mg/500mg/15mg Tablet SR whole; do not damage the tablet by chewing, crushing, or breaking it. Administer this medicine with food.
Common Side effects of Glimrox MP 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimrox MP 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet; avoid crushing, chewing, or breaking it. The Glimrox MP 1mg/500mg/15mg Sustained-Release tablet should be taken with a meal.
How Glimrox MP 1mg/500mg/15mg Tablet SR works:
Glimrox MP 1mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their complementary actions improve blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glimrox MP 1mg/500mg/15mg Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimrox MP 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible hazards prior to prescribing this medication. Seek medical advice before using this drug.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimrox MP 1mg/500mg/15mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Glimrox MP 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. For patients with severe kidney disease, Glimrox MP 1mg/500mg/15mg SR tablets are contraindicated. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimrox MP 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Medical advice is recommended. Glimrox MP 1mg/500mg/15mg SR tablets are contraindicated in those with severe hepatic dysfunction.
What if you forget to take Glimrox MP 1mg/500mg/15mg Tablet SR :
Should you forget a Glimrox MP 1mg/500mg/15mg SR Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimrox MP 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
